Corvus Pharmaceuticals, Inc. ($CRVS)
Filing Information
| Accession Number | 0001610717-26-000223 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 15, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
36,700
Total Value
$250,235.72
P&L
+74.5% (+$186,494.28)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 11, 2026 | Purchase | 21,700 | $11.53 | $250,235.72 | 21,700 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Grant/Award | 15,000 | $0.00 | $0.00 | 15,000 | Direct | โ | View Details |